Marshall Wace’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-192,465
| Closed | -$1.93M | – | 2674 |
|
|
2023
Q4 | $1.93M | Buy |
192,465
+72,976
| +61% | +$733K | ﹤0.01% | 1023 |
|
|
2023
Q3 | $344K | Sell |
119,489
-106,139
| -47% | -$306K | ﹤0.01% | 1546 |
|
|
2023
Q2 | $860K | Buy |
+225,628
| New | +$860K | ﹤0.01% | 1415 |
|
|
2022
Q2 | – | Sell |
-38,752
| Closed | -$89K | – | 3441 |
|
|
2022
Q1 | $89K | Sell |
38,752
-48,576
| -56% | -$112K | ﹤0.01% | 2482 |
|
|
2021
Q4 | $528K | Buy |
87,328
+17,022
| +24% | +$103K | ﹤0.01% | 2137 |
|
|
2021
Q3 | $975K | Sell |
70,306
-4,728
| -6% | -$65.6K | ﹤0.01% | 1573 |
|
|
2021
Q2 | $976K | Sell |
75,034
-25,399
| -25% | -$330K | ﹤0.01% | 1411 |
|
|
2021
Q1 | $1.55M | Buy |
+100,433
| New | +$1.55M | 0.01% | 1233 |
|